Small Molecules

04 Jul 2007 Biomira files investigational new drug application for PX-478, a novel inhibitor of hypoxia-inducible factor-1 alpha
04 Jul 2007 Teva Announces Approval Of Terbinafine Hcl Tablets
03 Jul 2007 Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
03 Jul 2007 VELCADE(R) (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
03 Jul 2007 Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
03 Jul 2007 Biogen Idec and cardiokine partner to develop Lixivaptan, a novel vasopressin antagonist
03 Jul 2007 Ceragenix(TM) Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
03 Jul 2007 Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
03 Jul 2007 Santhera Licenses Omigapil for Treatment of Rare Neuromuscular Diseases
03 Jul 2007 Newron reports positive Phase II results for ralfinamide in neuropathic pain
03 Jul 2007 Spectrum Pharmaceuticals Completes the NDA Filing for ISO-Vorin(TM)
03 Jul 2007 LEO Pharma Submits MAA for Daivobet(R) Scalp gel
03 Jul 2007 Kyoto University and Astellas Co-research at the Innovation Center for Immunoregulation Technologies and Drugs of Next Generation
03 Jul 2007 Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
02 Jul 2007 NicOx SA Initiates Third Pivotal Naproxcinod Phase 3 Study
30 Jun 2007 Rimonabant Regulatory Update in the United States
30 Jun 2007 Cyclacel Pharmaceuticals initiates Phase I study of CYC116 in patients with advanced solid tumors
30 Jun 2007 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstrom's Macroglobulinemia
30 Jun 2007 Akorn, Inc. Announces the New Drug Application Filing for Akten(R)
30 Jun 2007 Algeta Begins Clinical Dosimetry Study with Alpharadin in Prostate Cancer Patients
29 Jun 2007 Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
29 Jun 2007 CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
29 Jun 2007 INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
29 Jun 2007 Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
29 Jun 2007 Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up